Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
| Status: | Completed |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 2/20/2019 |
| Start Date: | November 2004 |
| End Date: | November 2009 |
A Prospective, Open Label Trial of High Dose UVA-1, 3x/Week or Medium Dose UVA-1, 3x/Week vs. Fluocinonide 0.05% Cream Treatment of Morphea
Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.
Inclusion Criteria:
- Male and female subjects 18 years of age or older.
- Symmetric limited morphea.
Exclusion Criteria:
- Known sensitivity to fluocinonide 0.05% cream.
- Clinical evidence of superinfected skin.
- Immunocompromised state (including previously documented HIV).
- Generalized Scleroderma.
- Previous history of skin cancer.
- Non-English speaking subjects.
We found this trial at
1
site
Dallas, Texas 75390
Click here to add this to my saved trials
